IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 30,477,080$31,017,7581.54%
SHENKMAN CAPITAL MANAGEMENT INC 17,691,000$17,931,7261.34%
BRAIDWELL LP 37,509,000$37,250,1881.18%
III Capital Management 16,200,000$16,068,4830.81%
DLD Asset Management, LP 7,500,000$7,471,8750.80%
TENOR CAPITAL MANAGEMENT Co., L.P. 34,375,000$34,057,6740.73%
Worth Venture Partners, LLC 1,034,000$1,029,4760.61%
CAPSTONE INVESTMENT ADVISORS, LLC 40,200,000$39,922,6200.18%
BOOTHBAY FUND MANAGEMENT, LLC 3,055,000$3,041,6340.07%
Leucadia National 7,149,000$7,051,5720.06%
Calamos Advisors LLC 5,000,000$4,970,7000.03%
Citadel Advisors 19,017,000$18,784,7340.00%
BANK OF MONTREAL /CAN/ 10,000,000$9,662,4000.00%
LAKE STREET ADVISORS GROUP, LLC 51,000$50,0000.00%
Arkadios Wealth Advisors 11,000$10,8140.00%
D.A. DAVIDSON & CO. 135,000$132,3810.00%
JANE STREET GROUP, LLC 3,000,000$2,981,2500.00%
Cetera Advisor Networks LLC 17,000$16,7130.00%
Cetera Advisors LLC 21,000$20,6450.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%

This page lists IRONWOOD PHARMACEUTICALS INC's shareholders in Q3 2023. To view IRONWOOD PHARMACEUTICALS INC's shareholder history, click here.